Product Images Candesartan Cilexetil

This text is prescribing information for Candesartan tablets with a strength of 4mg. The medication should be stored at a controlled room temperature and kept out of reach of children. The usual adult dosage, NDC number, and manufacturer information for Mylan Pharmaceuticals are also provided. The medication should be kept in a tightly closed, light-resistant container with a child-resistant closure. The lot and expiration date will be printed along with the variable data coding.*

This text is a medication label for tablets containing Candesartan cilexetil, USP 8 mg. The dosage instructions for adults are not provided, and users are instructed to refer to the accompanying prescribing information. The medication should be stored in a controlled room temperature between 20°C and 25°C and out of reach of children. The medication is manufactured by Mylan Pharmaceuticals Inc. in India and dispensed in a tight, light-resistant container with a child-resistant closure. The lot and expiration information for the medication can be found on the label.*

Candesartan cilexetil is a medication that comes in tablet form and contains 16 mg of USP. The usual adult dosage is not specified as it requires prescribing information. The medicine should be kept out of children's reach and stored at a temperature of 20 to 25°C (68 to 77°F). This product is manufactured by Mylan Pharmaceuticals Inc. in Morgantown, WY 26505, USA, and is made in India. The code number for the drugs is NHIDRUGS/25/NKD/B). The tablets are dispensed in a tightly closed, light-resistant container as defined in the USP, using a child-resistant closure. The provided information includes a prompt for LOT and EXP to be printed with variable data online Coding along with other information such as SNO and GTIN.*

This text seems to contain data related to medical history, medications, and clinical trials. It's likely a table or chart with results of a study on patients with certain medical conditions such as diabetes, hypertension, and atrial fibrillation. The table includes information about medications taken by patients and their performance in a study comparing Candesartan Cilexetil with Placebo. The hazard ratio for the treatment is also provided.*